Lisata Therapeutics Unveils Q1 2024 Financial Results
Company Announcements

Lisata Therapeutics Unveils Q1 2024 Financial Results

An update from Lisata Therapeutics (LSTA) is now available.

Lisata Therapeutics, Inc. has released its financial results for the first quarter of 2024, providing this latest update to investors and the public on May 9, 2024. Alongside the press release, the company has prepared a presentation for use at upcoming investor and industry conferences. These materials offer insight into the company’s current financial health and future prospects, intended to inform and engage stakeholders in the company’s ongoing performance and strategies.

For an in-depth examination of LSTA stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyLisata Therapeutics announces first patient treated with second-line CCA
GlobeNewswireLisata Therapeutics to Participate in Upcoming September 2024 Industry and Investor Events
TheFlyLisata Therapeutics granted FDA Orphan Drug Designation for certepetide
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App